Base4
1 known investors
BASE4 develops a molecular blood analysis that uses transcriptomics, genomics, and AI to measure how organs age and detect early biological alterations across multiple health systems. It offers programs for fertility and women's health, general full-body aging analysis, and pharma/clinical research applications such as tissue-level toxicity detection.
Investors · 1
Frequently asked questions
- What does Base4 do?
- BASE4 develops a molecular blood analysis that uses transcriptomics, genomics, and AI to measure how organs age and detect early biological alterations across multiple health systems. It offers programs for fertility and women's health, general full-body aging analysis, and pharma/clinical research applications such as tissue-level toxicity detection.
- Who are Base4's investors?
- Base4's investors include Kfund.